Coronavirus | Kejriwal extends Delhi lockdown till May 10
Updated:
Updated:
May 01, 2021 19:15 IST
This will be the second extension of the lockdown in the city to contain the COVID pandemic.
Share Article
Delhi Chief Minister Arvind Kejriwal addresses a press conference. File
| Photo Credit: PTI
This will be the second extension of the lockdown in the city to contain the COVID pandemic. Chief Minister Arvind Kejriwal on Saturday announced that the lockdown in the Capital would be extended by one more week. This means restrictions will be in place till May 10.
This will be the second extension of the lockdown in the city to contain the COVID pandemic and, effectively, mean that restrictions part of the measure remain in force continuously for three weeks.
India News: NEW DELHI: Clevira, a drug primarily developed to treat dengue, has been repurposed as supportive treatment for mild to moderate Covid-19 cases, its m.
Highlights
The NGO sought exemption of COVID-19 related drugs, medical equipment, other medical treatment for infection prevention, control measures and supportive care for patients from GST
The rate of infection, the positivity rate, as well as the rate of hospitalization for those requiring critical treatment have all increased exponentially with double mutant virus
The plea said that section 11 of the CGST Act confers the power of exemption from payment of GST on goods and services to the GST Council
New Delhi: A plea has been filed in the Supreme Court seeking GST exemption for Remdesivir, Tocilizumab, Favipiravir and other COVID-19 related drugs with a similar generic constitution as well as medical equipment.
April 30, 2021
The official Covid-19 treatment protocol in India continues to encourage the use of treatments that many scientists across the world have written off.
Even though these guidelines were revised by the country’s scientific task force on April 22, some of the recommendations in the new document are the same as the initial set that the government had announced in March 2020, when the world hardly knew anything about this virus and Covid-19 cases were only beginning to emerge in India.
A delay in updating these guidelines has led doctors to continue prescribing drugs such as hydroxychloroquine, favipiravir, and ivermectin, which showed early promise but were quickly found to be ineffective. It has also caused a panicked scurry for antiviral drug remdesivir, which became a popular therapy option as India’s case count kept surging past all previous records.